IL6 and neoplasm: Some of the tolerance mechanisms interfering with tumor clearing include the downregulation of HLA-I, the promotion of transforming growth factor-B (TGF-B) and vascular endothelial growth factor (VEGF) activity, and the release of IL-10 and IL-6 by cancerous cells, leading to the development and proliferation of malignancies [5].